A randomized trial of in-hospital initiation of an SGLT2 inhibitor in patients with heart failure missed its endpoint, but a meta-analysis with this trial showed benefit that included all-cause death.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/trial-data-support-hospital-initiation-sglt2-inhibitors-2025a1000o5q?src=rss
Author :
Publish date : 2025-09-12 08:08:00
Copyright for syndicated content belongs to the linked Source.
